Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Citi
Julphar
Federal Trade Commission
US Army
Covington
Moodys
Medtronic
AstraZeneca

Generated: June 25, 2018

DrugPatentWatch Database Preview

Exela Pharma Scs Llc Company Profile

« Back to Dashboard

What is the competitive landscape for EXELA PHARMA SCS LLC, and when can generic versions of EXELA PHARMA SCS LLC drugs launch?

EXELA PHARMA SCS LLC has seven approved drugs.

There is one US patent protecting EXELA PHARMA SCS LLC drugs.

Summary for Exela Pharma Scs Llc
US Patents:1
Tradenames:7
Ingredients:7
NDAs:7

Drugs and US Patents for Exela Pharma Scs Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Exela Pharma Scs Llc CAFFEINE CITRATE caffeine citrate SOLUTION;ORAL 077304-001 Sep 21, 2006 AA RX No No ➤ Sign Up ➤ Sign Up
Exela Pharma Scs Llc NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;IV (INFUSION) 209387-002 Dec 7, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up
Exela Pharma Scs Llc PANTOPRAZOLE SODIUM pantoprazole sodium POWDER;IV (INFUSION) 209463-001 Jun 30, 2017 RX No No ➤ Sign Up ➤ Sign Up
Exela Pharma Scs Llc VERAPAMIL HYDROCHLORIDE verapamil hydrochloride SOLUTION;INTRAVENOUS 018925-002 Apr 5, 2018 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Accenture
Farmers Insurance
Dow
Express Scripts
Federal Trade Commission
Colorcon
UBS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.